Alzheimer's disease: synaptic dysfunction and Aβ

被引:367
|
作者
Shankar, Ganesh M. [1 ,2 ]
Walsh, Dominic M. [3 ]
机构
[1] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Lab Neurodegenerat Res, Dublin 4, Ireland
来源
关键词
LONG-TERM POTENTIATION; MILD COGNITIVE IMPAIRMENT; SOLUBLE AMYLOID OLIGOMERS; PROTEIN TRANSGENIC MICE; TG2576 MOUSE MODEL; RAT DENTATE GYRUS; HIPPOCAMPAL-NEURONS; PLAQUE-FORMATION; MOLECULAR-BASIS; IN-VIVO;
D O I
10.1186/1750-1326-4-48
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Synapse loss is an early and invariant feature of Alzheimer's disease (AD) and there is a strong correlation between the extent of synapse loss and the severity of dementia. Accordingly, it has been proposed that synapse loss underlies the memory impairment evident in the early phase of AD and that since plasticity is important for neuronal viability, persistent disruption of plasticity may account for the frank cell loss typical of later phases of the disease. Extensive multi-disciplinary research has implicated the amyloid beta-protein (A beta) in the aetiology of AD and here we review the evidence that non-fibrillar soluble forms of A beta are mediators of synaptic compromise. We also discuss the possible mechanisms of A beta synaptotoxicity and potential targets for therapeutic intervention.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction
    Chakroborty, Shreaya
    Stutzmann, Grace E.
    SCIENCE CHINA-LIFE SCIENCES, 2011, 54 (08) : 752 - 762
  • [32] The Role of Glial Cells in Synaptic Dysfunction: Insights into Alzheimer's Disease Mechanisms
    Yu, Yang
    Chen, Ran
    Mao, Kaiyue
    Deng, Maoyan
    Li, Zhigang
    AGING AND DISEASE, 2024, 15 (02): : 459 - 479
  • [33] Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer's Disease
    Dulewicz, Maciej
    Kulczynska-Przybik, Agnieszka
    Slowik, Agnieszka
    Borawska, Renata
    Mroczko, Barbara
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [34] Microglia exacerbates amyloid-induced synaptic dysfunction in Alzheimer's disease
    Capetillo-Zarate, E.
    Zuazo, J.
    Ortiz-Sanz, C.
    Alberdi, E.
    Matute, C.
    GLIA, 2017, 65 : E177 - E178
  • [35] ZCCHC17 is a potential driver of synaptic dysfunction in Alzheimer's Disease
    Teich, Andrew
    Tomljanovic, Zeljko
    Patel, Mitesh
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2016, 75 (06): : 573 - 573
  • [36] Synaptic dysfunction in Alzheimer's disease: Clinical assessment using quantitative EEG
    Cook, IA
    Leuchter, AF
    BEHAVIOURAL BRAIN RESEARCH, 1996, 78 (01) : 15 - 23
  • [37] Early calcium dysregulation in Alzheimer's disease:setting the stage for synaptic dysfunction
    Shreaya CHAKROBORTY
    Grace E.STUTZMANN
    Science China Life Sciences, 2011, 54 (08) : 752 - 762
  • [38] Early calcium dysregulation in Alzheimer’s disease: setting the stage for synaptic dysfunction
    Shreaya Chakroborty
    Grace E. Stutzmann
    Science China Life Sciences, 2011, 54 : 752 - 762
  • [39] Targeting Synaptic Dysfunction in Alzheimer's Disease by Administering a Specific Nutrient Combination
    van Wijk, Nick
    Broersen, Laus M.
    de Wilde, Martijn C.
    Hageman, Robert J. J.
    Groenendijk, Martine
    Sijben, John W. C.
    Kamphuis, Patrick J. G. H.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 38 (03) : 459 - 479
  • [40] Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease
    Proctor, Dustin T.
    Coulson, Elizabeth J.
    Dodd, Peter R.
    PROGRESS IN NEUROBIOLOGY, 2011, 93 (04) : 509 - 521